Form 4: Reliance Global Group Director Acquires Shares Through Stock Grant
SEC Form 4 Filing
Director Ben Fruchtzweig acquired 10,990 shares of Reliance Global Group, Inc. common stock through a grant approved by the compensation committee.
Summary
- On February 5, 2025, Ben Fruchtzweig, a director of Reliance Global Group, Inc., acquired 10,990 shares of common stock.
- The acquisition was a grant approved by the compensation committee, comprised solely of independent directors.
- The shares were issued in accordance with Rule 16b-3 under the Securities Exchange Act of 1934.
- The grant fully vests on February 13, 2025.
- Following the transaction, Fruchtzweig directly owns 63,746 shares of Reliance Global Group, Inc.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction (stock grant) and suggests alignment of director's interests with shareholders, leading to a moderately positive sentiment.
Positives
- The stock grant aligns the director's interests with those of the shareholders.
- The compensation committee's approval indicates independent oversight of executive compensation.
Industry Context
Stock grants are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.
Stakeholder Impact
- The stock grant could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/05/2025 | Date of transaction: acquisition of shares |
| 02/07/2025 | Date of Form 4 filing |
| 02/13/2025 | Grant fully vests |
Keywords
Reliance Global Group, Director, Stock Grant, Beneficial Ownership, Form 4, RELI, Fruchtzweig
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.